Primary Care Vasculitis Polymyalgia Rheumatica and Giant Cell Arteritis

被引：2

作者：

Pioro, Mathilde H. ^{[1
,2
]}

机构：

[1] Cleveland Clin, Orthoped & Rheumatol Inst, Dept Rheumatol, 9500 Euclid Ave A50, Cleveland, OH 44195 USA

[2] Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, 9500 Euclid Ave A50, Cleveland, OH 44195 USA

来源：

PRIMARY CARE | 2018年 / 45卷 / 02期

关键词：

Polymyalgia rheumatica; Giant cell arteritis; Temporal artery biopsy; Corticosteroids; Tocilizumab; SERONEGATIVE SYMMETRICAL SYNOVITIS; ERYTHROCYTE SEDIMENTATION-RATE; POSITRON-EMISSION-TOMOGRAPHY; PLACEBO-CONTROLLED TRIAL; PITTING EDEMA RS3PE; C-REACTIVE PROTEIN; DOUBLE-BLIND; TEMPORAL ARTERITIS; FOLLOW-UP; CLINICAL-FEATURES;

D O I：

10.1016/j.pop.2018.02.007

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

Polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) are related inflammatory diseases of adults aged 50 years or older. The diagnosis of PMR is based on morning stiffness, proximal shoulder and pelvic girdle pain, and functional impairment. GCA is characterized by headache, jaw claudication, and visual disturbances. Constitutional symptoms and elevated inflammatory markers are common to both conditions. Temporal artery biopsy remains the gold standard for diagnosis of GCA. Glucocorticoids are the cornerstone of therapy, with tapering regimens individualized to the patient. Prompt diagnosis and treatment are essential to avert vision loss in GCA. Tocilizumab increases remission rates in GCA.

引用

下载

页码：305 / +

页数：20

共 50 条

[1] Lower extremity vasculitis in polymyalgia rheumatica and giant cell arteritis
Kermani, Tanaz A.
Warrington, Kenneth J.
CURRENT OPINION IN RHEUMATOLOGY, 2011, 23 (01) : 38 - 42
[2] The prevalence of giant cell arteritis and polymyalgia rheumatica in a UK primary care population
Max Yates
Karly Graham
Richard Arthur Watts
Alexander James MacGregor
BMC Musculoskeletal Disorders, 17
[3] THE PREVALENCE OF GIANT CELL ARTERITIS AND POLYMYALGIA RHEUMATICA IN A UK PRIMARY CARE POPULATION
Yates, Max
Graham, Karly
Watts, Richard A.
MacGregor, Alex J.
RHEUMATOLOGY, 2015, 54 : 65 - 66
[4] The prevalence of giant cell arteritis and polymyalgia rheumatica in a UK primary care population
Yates, Max
Graham, Karly
Watts, Richard Arthur
MacGregor, Alexander James
BMC MUSCULOSKELETAL DISORDERS, 2016, 17
[5] Giant cell arteritis and polymyalgia rheumatica
Marin Gonzalez, G.
MAYO CLINIC PROCEEDINGS, 2007, 82 (01) : 133 - 133
[6] Polymyalgia Rheumatica and Giant Cell Arteritis
Makhzoum, Jean-Paul
JOURNAL OF RHEUMATOLOGY, 2016, 43 (11) : 2088 - 2088
[7] Polymyalgia Rheumatica and Giant Cell Arteritis
Macejova, Z.
Oetterova, M.
PROCEEDINGS OF THE ASIA PACIFIC GERIATRIC CONFERENCE, APGC, 2008, : 43 - 45
[8] Giant cell arteritis and polymyalgia rheumatica
Hunder, GG
MEDICAL CLINICS OF NORTH AMERICA, 1997, 81 (01) : 195 - &
[9] Polymyalgia rheumatica and giant cell arteritis
Patel, Martyn
Forsyth, Duncan R.
JOURNAL OF CLINICAL GERONTOLOGY & GERIATRICS, 2011, 2 (01): : 7 - 12
[10] POLYMYALGIA RHEUMATICA AND GIANT CELL ARTERITIS
KLINEFELTER, HF
JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1971, 215 (04) : 642 - +

← 1 2 3 4 5 →